The global optical imaging system market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.5 Billion by 2033, exhibiting a growth rate (CAGR) of 8.74% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.0 Billion |
Market Forecast in 2033
|
USD 4.5 Billion |
Market Growth Rate 2025-2033 | 8.74% |
An optical imaging system utilizes photons of light to obtain detailed images of small structures, such as cells and molecules, in human, animal and plant tissues. It relies on non-ionizing radiation for reducing exposure to harmful radiation as compared to radiological imaging techniques. It can also be combined with other imaging techniques, such as magnetic resonance imaging (MRI) or X-rays, to provide enhanced information on complex diseases or experiments. Consequently, it finds extensive applications in genomics, proteomics, cell biology, and drug discovery and development.
The optical imaging system is gaining traction as a real-time, sensitive and noninvasive modality for visualization, localization and measurement of bioactive molecules and molecular processes in vivo. It is also used as an essential tool for studying small-animal models and providing unique insights into disease pathogenesis, drug development and effects of therapy. Apart from this, researchers are using near-infrared (NIR) brain imaging to guide cerebral palsy treatment in pediatric patients. They are also developing miniature scanning laser microscopes to combine high-resolution images with wide-field color video images and improve early cancer diagnosis. The rising number of individuals suffering from cancer and the increasing geriatric population are further contributing to the market growth. Moreover, optical imaging is finding extensive applications in clinical diagnostics and preclinical research in various therapeutic areas, which is augmenting the growth of the market. Other factors, such as rising investments in research and development (R&D) activities, are anticipated to drive the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optical imaging system market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on technique, products, therapeutic area, application and end user.
Breakup by Technique:
Breakup by Products:
Breakup by Therapeutic Area:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioptigen Inc. (Leica Microsystems), Canon Inc., Carl Zeiss Meditec AG, Headwall Photonics Inc., Heidelberg Engineering Inc., Koninklijke Philips, Optovue Inc., PerkinElmer Inc., St. Jude Medical Inc. and Topcon Corporation.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Technique, Products, Therapeutic Area, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, Bioptigen Inc. (Leica Microsystems), Canon Inc., Carl Zeiss Meditec AG, Headwall Photonics Inc., Heidelberg Engineering Inc., Koninklijke Philips, Optovue Inc., PerkinElmer Inc., St. Jude Medical Inc., Topcon Corporation |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the global optical imaging system market to exhibit a CAGR of 8.74% during 2025-2033.
The rising prevalence of cancer, along with the increasing need for Magnetic Resonance Imaging (MRI) or X-rays to diagnose complex diseases, is primarily driving the global optical imaging system market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective imaging and diagnostic tests to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for optical imaging systems.
Based on the technique, the global optical imaging system market can be segmented into optical coherence tomography, hyperspectral imaging, near-infrared spectroscopy, photoacoustic tomography, and others. Currently, optical coherence tomography holds the majority of the total market share.
Based on the products, the global optical imaging system market has been divided into imaging system, software, lenses, illumination systems, cameras, and others. Among these, imaging system currently exhibits a clear dominance in the market.
Based on the therapeutic area, the global optical imaging system market can be categorized into neurology, oncology, ophthalmology, cardiology, dentistry, dermatology, and others. Currently, oncology accounts for the majority of the global market share.
Based on the application, the global optical imaging system market has been segregated into pre-clinical and clinical research, pathological imaging, and intra-operative imaging, where pathological imaging currently holds the largest market share.
Based on the end user, the global optical imaging system market can be bifurcated into hospitals and clinics, research and diagnostic laboratories, and pharmaceutical and biotechnology companies. Currently, research and diagnostic laboratories exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global optical imaging system market include Abbott Laboratories, Bioptigen Inc. (Leica Microsystems), Canon Inc., Carl Zeiss Meditec AG, Headwall Photonics Inc., Heidelberg Engineering Inc., Koninklijke Philips, Optovue Inc., PerkinElmer Inc., St. Jude Medical Inc., and Topcon Corporation.